Search

everythinglearnresearchcommunity

for

Search:↓

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

Hormonal therapies are safe and effective for treating adult women's acne.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

The skin is a complex barrier that protects the body, regulates temperature, and helps with immune responses.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Madarosis is the loss of eyelashes and eyebrows due to various health issues and requires thorough examination to diagnose and treat the underlying cause.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Hedychium spicatum has medicinal properties but needs more research for scientific validation and use.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.